Supernus Corp (SUPN) Forvard narx/daromad multiplikatori
Supernus Pharmaceuticals (SUPN) ADHD va epilepsiya dori vositalariga bo'lgan barqaror talabga tayanadi. Forward narx-savdo koeffitsiyenti aktivning dinamikasini aks ettiradi va uning so'nggi qiymati 2.50 deb qayd etilgan. Biroq, savdo to'siqlari va tartibga soluvchi nazorat kengayish uchun qiyinchiliklar yaratmoqda. Shu bilan birga, CNS rivojlantirishga konservativ yondashuv brendning professional tibbiyot hamjamiyati orasida pragmatik ishonchni saqlab qolishini ta'minlaydi.
supernus.com (SUPN) kompaniyasi koʻrsatkichlari kesimi va tahlili
- bozor narxi va tahlilchilarning maqsadli narxlari:
- bozor kapitallashuvi tafsilotlari:
- biznesning balans baholash tafsilotlari:
- qarzlar va to'lov qobiliyati haqida ma'lumot:
Umumiy qarzning kapitalga nisbati Supernus Pharmaceuticals|SUPN - Uzoq muddatli qarzning kapitalga nisbati|Qisqa muddatli qarzning o'z kapitaliga nisbati Supernus|SUPN - Jamlangan qarz majburiyatlari|Qarzning balans kapitallashuviga nisbati Supernus Pharmaceuticals, Inc.|SUPN - Kompaniyaning uzoq muddatli majburiyatlari|Kompaniyaning qisqa muddatli qarzlari Supernus|Tezkor likvidlik koeffitsiyenti supernus.com
- biznes foydasi va investitsiya koeffitsiyentlari ma'lumotlari:
SUPN - Sof daromad|Prognoz qilingan kelajakdagi foyda Supernus Pharmaceuticals|SUPN - Kapitalizatsiyaning foydaga nisbati|Prognoz qilingan narxning foydaga nisbati Supernus Corp|SUPN - PEG multiplikatori|Korxona qiymatining foizlar, soliqlar va amortizatsiyadan oldingi foydaga nisbati koeffitsiyenti Supernus Corp|SUPN - Kompaniyaning soliqlar, foizlar va amortizatsiyadan oldingi foydasi|Bir aksiya uchun sof foyda (EPS TTM) Supernus|SUPN - So'nggi to'rtta chorak uchun bir aksiya uchun sof foyda|Choraklik EPS foyda o'sishi supernus.com|SUPN - Bu yil bir aksiya uchun sof foyda o'sishi|Keyingi yil uchun foyda o'sishi prognozi Supernus Pharmaceuticals
- sotuv hajmi va tushum haqida ma'lumot:
Kompaniyaning jamlanma tahlili:SUPN (Supernus Corp)
Oldingi P/S koeffitsiyenti joriy bozor kapitalizatsiyasini kelajakdagi savdo hajmlari bilan solishtirish orqali kutilayotgan daromadlar kengayishining bozor premiumini aks ettiradi. Supernus Pharmaceuticals (SUPN) uchun ushbu metrika sotib olingan patentlarning integratsiya samaradorligini va neyrofarmatsevtika ittifoqlarining sinergiyasini baholaydi, bu esa oldingi P/S koeffitsiyentiga fundamental biznes o'sishini spekulyativ bozor tebranishlaridan ajratish imkonini beradi.
Supernus Pharmaceuticals (SUPN) raqobatchilari
Forvard P/S multiplikatori BIIB (Biogen Idec)|Kapitalizatsiyaning kutilayotgan sotuvga nisbati Neurocrine Corp (NBIX)|RGC: Forvard narx/daromad multiplikatori|Sotuvga nisbatan forvard narx AXSM (Axsome Therapeutics)|ACAD: Forvard P/S multiplikatori|Xenon Pharmaceuticals Inc. - Sotuvga nisbatan forvard narx|Narxning prognoz qilingan daromadga nisbati Viking Pharma|CPRX: Sotuvga nisbatan forvard narx|Forvard P/S multiplikatori DNLI|Kapitalizatsiyaning kutilayotgan sotuvga nisbati Harmony Biosciences|Biohaven Ltd - Forvard narx/daromad multiplikatori|Forvard P/S multiplikatori Amylyx Pharmaceuticals, Inc. AMLX|TRVI: Forvard narx/daromad multiplikatori|Kapitalizatsiyaning kutilayotgan sotuvga nisbati Praxis Corp PRAX|AVXL: Forvard P/S multiplikatori|CBLL (ceribell.com) - Narxning prognoz qilingan daromadga nisbati|PRTA (Prothena Corporation) - Forvard P/S multiplikatori|Forvard narx/daromad multiplikatori alector.com (ALEC)|Narxning prognoz qilingan daromadga nisbati Annexon, Inc. (ANNX)|OMER - Bozor kapitallashuvining kelajakdagi daromadga nisbati|Forvard P/S multiplikatori NGNE (Neurogene Inc)|AC Immune (ACIU) - Bozor kapitallashuvining kelajakdagi daromadga nisbati|Voyager Therapeutics Inc - Forvard P/S multiplikatori|Neumora (NMRA) - Forvard narx/daromad multiplikatori|SCLX: Forvard P/S multiplikatori|TVGN - Kapitalizatsiyaning kutilayotgan sotuvga nisbati|ACOG (Alpha Cognition Inc) - Forvard P/S multiplikatori|Forvard narx/daromad multiplikatori cogrx.com (CGTX)|Narxning prognoz qilingan daromadga nisbati Inhibikase Therapeutics Inc (IKT)|Kapitalizatsiyaning kutilayotgan sotuvga nisbati Cassava Sciences|Forvard P/S multiplikatori ASRT (Assertio Holdings)|COYA - Forvard narx/daromad multiplikatori|vistagen.com - Forvard P/S multiplikatori|OVID: Narxning prognoz qilingan daromadga nisbati|Acumen Pharmaceuticals, Inc (ABOS) - Narxning prognoz qilingan daromadga nisbati|CervoMed Inc - Sotuvga nisbatan forvard narx|Narxning prognoz qilingan daromadga nisbati Alterity Therapeutics Limited|clene.com (CLNN) - Kapitalizatsiyaning kutilayotgan sotuvga nisbati|Forvard narx/daromad multiplikatori PEPG (PepGen Inc)|Forvard P/S multiplikatori jupiterneurosciences.com (JUNS)|Narxning prognoz qilingan daromadga nisbati Relmada Therapeutics, Inc. RLMD|ANVS: Kapitalizatsiyaning prognoz qilingan daromadga nisbati|Grace Tx - Forvard P/S multiplikatori|AIFF (Firefly Neuroscience Inc) - Kapitalizatsiyaning prognoz qilingan daromadga nisbati|KLTO: Forvard P/S multiplikatori|NeuroSense Therapeutics, Ltd. (NRSN) - Forvard P/S multiplikatori|Narxning prognoz qilingan daromadga nisbati Reviva Pharmaceuticals, Inc.|Forvard narx/daromad multiplikatori metaviatx.com (MTVA)|Forvard P/S multiplikatori NRXS|HSDT - Bozor kapitallashuvining kelajakdagi daromadga nisbati|Passage Bio, Inc. - Forvard narx/daromad multiplikatori|bionomics.com.au (NEUP) - Bozor kapitallashuvining kelajakdagi daromadga nisbati|Minerva - Forvard P/S multiplikatori|Sotuvga nisbatan forvard narx ATHA (Athira Pharma Inc)|ADXN: Forvard P/S multiplikatori|Kapitalizatsiyaning prognoz qilingan daromadga nisbati ALZN|CYCN (Cyclerion Therapeutics Inc.) - Forvard P/S multiplikatori|PTIX (Protagenic Therapeutics) - Narxning kutilayotgan daromadga nisbati|Forvard P/S multiplikatori KTTA|Kapitalizatsiyaning kutilayotgan sotuvga nisbati Cortigent|Forvard P/S multiplikatori ATXI (avenuetx.com)|BrainStorm Cell Therapeutics Inc. - Narxning prognoz qilingan daromadga nisbati|Cara Therapeutics Inc. - Forvard P/S multiplikatori|Chromocell Therapeutics (CHRO) - Forvard narx/daromad multiplikatori|ELYM: Forvard P/S multiplikatori|Forvard narx/daromad multiplikatori Intra-Cellular Therapies Inc.|LBPH (Longboard Pharmaceuticals Inc) - Forvard P/S multiplikatori|Marinus - Kelajakdagi narxning daromadga nisbati|Forvard P/S multiplikatori NKGN|NRBO (NeuroBo Pharmaceuticals) - Sotuvga nisbatan forvard narx|Forvard P/S multiplikatori SAGE (Sage Therapeutics Inc)|Kapitalizatsiyaning kutilayotgan sotuvga nisbati Synaptogenix Inc. (SNPX)|TRVN - Narxning prognoz qilingan daromadga nisbati|vigilneuro.com (VIGL) - Forvard narx/daromad multiplikatori|WENA: Forvard P/S multiplikatori|Cerevel Therapeutics, Inc. (CERE) - Forvard P/S multiplikatori
